Clinical Trial Update: Non-interventional Treatment Patterns Study in Chronic Phase Chronic Myelogenous Leukemia (CP-CML)

View source ↗

Summary

This entry notes the completion of a non-interventional treatment-patterns study in chronic phase chronic myeloid leukemia, sponsored by Bristol-Myers Squibb. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Sprycel (dasatinib)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Chronic Myeloid Leukemia | Status: COMPLETED